Soligenix, Inc. (SNGX), a late-stage biopharmaceutical company, has surged 14.35% in aftermarket trading session. Consequently, SNGX is trading at $0.95 at the time of the writing.
As of today’s premarket session, shares of Soligenix Inc. (SNGX) have fallen by -9.16% to $1.19. Soligenix stock added 25.96% to finish the last trading
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.